How the CORAL software can be used to select compounds for efficient treatment of neurodegenerative diseases?

Toropova AP, Toropov AA, Leszczynska D, Leszczynski J. How the CORAL software can be used to select compounds for efficient treatment of neurodegenerative diseases? Toxicol Appl Pharmacol. 2020 12 01; 408:115276.

View in: PubMed

subject areas

Models, Molecular
Monte Carlo Method
Neurodegenerative Diseases
Neuroprotective Agents
Quantitative Structure-Activity Relationship
Receptor, trkA
Receptors, N-Methyl-D-Aspartate
Software

authors with profiles

Jerzy Leszczynski

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support